Cell therapy equipment manufacturer Aglaris has appointed Steven Docksey as its new CEO. Previously, Steven held senior leadership and operational roles with Merck Millipore, Sartorius Stedim and GE Healthcare. Most recently he was adviser and non-executive director at Puridify and was instrumental in its sale to GE Healthcare following strong industry interest. During his career, Steven has been responsible for the successful commercialisation of numerous technology-led tools and technology platforms across the global pharma industry.